[Inhibition of pancreatic apudoma-dependent hypersecretion of gastrin, glucagon and serotonin using somatostatin-14].
D000328:Adult; D002276:Carcinoid Tumor / Q000378:metabolism; D005260:Female; D005755:Gastrins / Q000378:metabolism*; D005934:Glucagon / Q000378:metabolism*; D005935:Glucagonoma / Q000378:metabolism; D006801:Humans; D006897:Hydroxyindoleacetic Acid / Q000652:urine; D008297:Male; D008875:Middle Aged; D010190:Pancreatic Neoplasms / Q000378:metabolism*; D012701:Serotonin / Q000378:metabolism*; D013004:Somatostatin / Q000627:therapeutic use*; D015043:Zollinger-Ellison Syndrome / Q000378:metabolism
D005755:Gastrins; D012701:Serotonin; D013004:Somatostatin; D006897:Hydroxyindoleacetic Acid; D005934:Glucagon
Inhibición de la hipersecreción de gastrina, glucagón y serotonina dependiente de apudomas pancreáticos, mediante somatostatina-14.